The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ ...

Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of "profiteering and dysfunction" ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Hold rating on Medtronic (MDT – Research Report), with a price ...

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

The pink, white and red blob of tissue quivers in a vat of clear goop about the size of a kitchen sink. Graduate students whiz around this slimy beating heart and crawl under the tubes connected to ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Rose brings medical device leadership and commercialization expertise to the company as it prepares to enter into U.S. and European pivotal clinical trials of UroActive, the first smart automated ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...

What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Walter, SVP at Medtronic, exercising stock options for 1,337 shares of MDT. The total ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...